We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+10.26%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$1.43B
AUM Growth
+$167M
Cap. Flow
+$55.7M
Cap. Flow %
3.88%
Top 10 Hldgs %
33.03%
Holding
148
New
41
Increased
26
Reduced
22
Closed
44

Top Buys

Rank Stock Value
1
CHRD icon
Chord Energy
CHRD
+$28.8M
2
DVN icon
Devon Energy
DVN
+$24.8M
3
A icon
Agilent Technologies
A
+$22.5M
4
MSFT icon
Microsoft
MSFT
+$18.9M
5
TSG
The Stars Group Inc.
TSG
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Technology 16.97%
3 Materials 8.62%
4 Industrials 7.83%
5 Consumer Staples 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
76
CALL
Kimberly-Clark
KMB
$37B
$5.27M 0.37%
+50,000
New +$5.19M
EACQ
77
DELISTED
Easterly Acquisition Corp
EACQ
$5.15M 0.36%
500,000
GEG icon
78
Great Elm Group
GEG
$67.4M
$4.56M 0.32%
1,267,030
MDLZ icon
79
Mondelez International
MDLZ
$79.2B
$4.22M 0.29%
102,915
-428,892
-81% -$17.2M
CLX icon
80
CALL
Clorox
CLX
$12.7B
$4.06M 0.28%
+30,000
New +$3.7M
BABA icon
81
Alibaba
BABA
$309B
$4.04M 0.28%
21,754
-13,285
-38% -$2.53M
CCJ icon
82
Cameco
CCJ
$40.5B
$3.67M 0.26%
+325,883
New +$3.55M
LOW icon
83
Lowe's Companies
LOW
$122B
$3.34M 0.23%
+34,911
New +$3.16M
RCL icon
84
Royal Caribbean
RCL
$87.1B
$2.88M 0.2%
27,756
-39,753
-59% -$4.37M
SGYP
85
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2.44M 0.17%
1,403,149
+26,441
+2% +$45.7K
STDY
86
DELISTED
SteadyMed Ltd
STDY
$2.26M 0.16%
503,140
SWK icon
87
Stanley Black & Decker
SWK
$15.5B
$2.26M 0.16%
+17,000
New +$2.45M
STZ icon
88
Constellation Brands
STZ
$22.4B
$2.25M 0.16%
+10,268
New +$2.32M
CZR icon
89
Caesars Entertainment
CZR
$6.14B
$2.06M 0.14%
+52,573
New +$2.17M
IVTY
90
DELISTED
Invuity, Inc
IVTY
$1.8M 0.13%
462,079
+312,079
+208% +$1.08M
BLMN icon
91
Bloomin' Brands
BLMN
$764M
$1.55M 0.11%
+77,004
New +$1.75M
SLGL icon
92
Sol-Gel Technologies
SLGL
$276M
$1.46M 0.1%
18,926
+342
+2% +$31.3K
METC icon
93
Ramaco Resources Class A
METC
$630M
$1.38M 0.1%
+205,311
New +$1.46M
DEST
94
DELISTED
Destination Maternity Corporation
DEST
$626K 0.04%
+107,495
New +$373K
JAGX icon
95
Jaguar Health
JAGX
$4.91M
0
ADM icon
96
Archer Daniels Midland
ADM
$38.5B
-146,101
Closed -$6.34M
AIG icon
97
American International
AIG
$42.1B
-324,015
Closed -$17.6M
AMAT icon
98
Applied Materials
AMAT
$434B
-428,873
Closed -$23.9M
ARCT icon
99
Arcturus Therapeutics
ARCT
$177M
-28,426
Closed -$156K
BIIB icon
100
Biogen
BIIB
$30.8B
-10,076
Closed -$2.76M

Similar funds

Kingdon Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Kingdon Capital Management held 148 positions worth $1.43B, up 13% from $1.27B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kingdon Capital Management deployed $55.7M of net new capital in Q2 2018, opening 41 new positions and adding to 26 existing holdings. Its largest new stake was Chord Energy: 2,531,189 shares worth $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Heron Therapeutics, an estimated $27.3M trimmed.

  • Kingdon Capital Management's largest Q2 2018 buy was Chord Energy: 2,531,189 shares worth $32.8M.
  • Kingdon Capital Management added most to Caesars Entertainment Corporation in Q2 2018, an estimated $12.9M increase.
  • Kingdon Capital Management's biggest Q2 2018 reduction was Heron Therapeutics, cutting an estimated $27.3M.
  • Kingdon Capital Management fully exited Micron Technology in Q2 2018, selling an estimated $41.1M.
  • Kingdon Capital Management's ten largest holdings make up 33% of its $1.43B portfolio in Q2 2018.
  • Kingdon Capital Management opened 41 new positions and closed 44 in Q2 2018.
  • Kingdon Capital Management's portfolio value rose 13% quarter-over-quarter to $1.43B.

Based on Kingdon Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.